NMOSD — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Spinal cord infarction
LETM (≥3 vertebral segments) with positive AQP4-IgG antibodies is diagnostic of NMOSD (formerly Devic's disease). This is a critical distinction from MS because the treatments differ – some MS therapies (fingolimod, natalizumab) can WORSEN NMOSD. Acute treatment is high-dose IV methylprednisolone; plasma exchange for steroid-refractory attacks. Long-term prevention uses rituximab, eculizumab, inebilizumab, or satralizumab (all with evidence from RCTs – PREVENT, N-MOmentum, SAkuraSky trials).
Reference: eTG – 2025 – Neurology; Wingerchuk et al – 2015 – NMOSD Diagnostic Criteria